Amid uproar over delays authorizing COVID-19 vaccines for children younger than 5, the US Food and Drug Administration plans to soon provide a tentative advisory committee schedule for the applications expected at the agency that could offer some certainty to anxious parents.
However, Center for Biologics Evaluation and Research Director Peter Marks warned that the agency cannot finish its review without a...







